MXPA03008083A - Anticuerpo monoclonal especifico para epitopo de glicoproteina codificada por inmunodeficiencia felina inactivada. - Google Patents
Anticuerpo monoclonal especifico para epitopo de glicoproteina codificada por inmunodeficiencia felina inactivada.Info
- Publication number
- MXPA03008083A MXPA03008083A MXPA03008083A MXPA03008083A MXPA03008083A MX PA03008083 A MXPA03008083 A MX PA03008083A MX PA03008083 A MXPA03008083 A MX PA03008083A MX PA03008083 A MXPA03008083 A MX PA03008083A MX PA03008083 A MXPA03008083 A MX PA03008083A
- Authority
- MX
- Mexico
- Prior art keywords
- epitope
- monoclonal antibody
- antibody specific
- feline immunodeficiency
- inactivated
- Prior art date
Links
- 241000282324 Felis Species 0.000 title 1
- 102000003886 Glycoproteins Human genes 0.000 title 1
- 108090000288 Glycoproteins Proteins 0.000 title 1
- 206010061598 Immunodeficiency Diseases 0.000 title 1
- 208000029462 Immunodeficiency disease Diseases 0.000 title 1
- 241000713800 Feline immunodeficiency virus Species 0.000 abstract 4
- 101710121417 Envelope glycoprotein Proteins 0.000 abstract 1
- 108010052285 Membrane Proteins Proteins 0.000 abstract 1
- 102000018697 Membrane Proteins Human genes 0.000 abstract 1
- 102100021696 Syncytin-1 Human genes 0.000 abstract 1
- 235000004252 protein component Nutrition 0.000 abstract 1
- 238000011002 quantification Methods 0.000 abstract 1
- 229960005486 vaccine Drugs 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/08—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses
- C07K16/10—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses from RNA viruses
- C07K16/1036—Retroviridae, e.g. leukemia viruses
- C07K16/1045—Lentiviridae, e.g. HIV, FIV, SIV
- C07K16/1063—Lentiviridae, e.g. HIV, FIV, SIV env, e.g. gp41, gp110/120, gp160, V3, PND, CD4 binding site
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Virology (AREA)
- Immunology (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Oncology (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Hematology (AREA)
- AIDS & HIV (AREA)
- General Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Communicable Diseases (AREA)
- Peptides Or Proteins (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Abstract
La presente invencion se refiere un anticuerpo monoclonal especifico para un epitopo que es unico para el componente de proteina de superficie de una glicoproteina de envoltura de virus de inmunodeficiencia felina inactivado (FIV). Dicho anticuerpo es util para la cuantificacion del FIV inactivado o la determinacion de la potencia de una vacuna de FIV inactivado.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US41024602P | 2002-09-12 | 2002-09-12 |
Publications (1)
Publication Number | Publication Date |
---|---|
MXPA03008083A true MXPA03008083A (es) | 2004-11-29 |
Family
ID=31888412
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MXPA03008083A MXPA03008083A (es) | 2002-09-12 | 2003-09-08 | Anticuerpo monoclonal especifico para epitopo de glicoproteina codificada por inmunodeficiencia felina inactivada. |
Country Status (22)
Country | Link |
---|---|
US (1) | US7345152B2 (es) |
EP (2) | EP2281838A1 (es) |
JP (1) | JP4472298B2 (es) |
KR (1) | KR101114268B1 (es) |
CN (1) | CN1528791B (es) |
AR (1) | AR041230A1 (es) |
AT (1) | ATE553126T1 (es) |
AU (2) | AU2003246049A1 (es) |
BR (1) | BR0303500B1 (es) |
CO (1) | CO5500021A1 (es) |
CY (1) | CY1112710T1 (es) |
DK (1) | DK1398325T3 (es) |
ES (1) | ES2383075T3 (es) |
HR (1) | HRP20030729A2 (es) |
MX (1) | MXPA03008083A (es) |
NZ (1) | NZ528160A (es) |
PL (1) | PL362164A1 (es) |
PT (1) | PT1398325E (es) |
RS (1) | RS51739B (es) |
SI (1) | SI1398325T1 (es) |
TW (1) | TW200406421A (es) |
ZA (1) | ZA200307119B (es) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1624785B1 (en) | 2003-01-17 | 2013-07-17 | Aethlon Medical, Inc. | Method for removal of viruses from blood by lectin affinity hemodialysis |
CN102735853B (zh) * | 2012-06-07 | 2014-06-04 | 广州市华南农大生物药品有限公司 | 一种猪流感灭活疫苗的效价测定方法 |
RU2018123480A (ru) * | 2015-12-23 | 2020-01-24 | Интервет Интернэшнл Б.В. | Вакцина против кошачьего калицивируса |
CN110501509A (zh) * | 2019-09-03 | 2019-11-26 | 长春西诺生物科技有限公司 | 一种抗猫细小病毒猫源化基因工程抗体elisa试剂盒及其检测方法 |
Family Cites Families (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6107077A (en) * | 1987-08-26 | 2000-08-22 | Yamamoto; Janet K. | Feline lymphoid cell lines capable of producing FIV for FIV diagnostics and vaccines |
CA1341439C (en) * | 1987-08-26 | 2003-09-23 | Niels C. Pedersen | Feline t-lymphotropic lentivirus |
US5219725A (en) * | 1988-12-05 | 1993-06-15 | Idexx Laboratories Incorporated | Monoclonal antibodies to feline-t-lymphotropic lentivirus |
US5177014A (en) * | 1988-12-05 | 1993-01-05 | Idexx Laboratories, Inc. | Monoclonal antibodies to feline-T-lymphotropic lentivirus |
US6228608B1 (en) | 1991-02-28 | 2001-05-08 | Aquila Biopharmaceuticals, Inc. | Recombinant FIV glycoprotein 160 and P24 gag protein |
GB9215233D0 (en) | 1992-07-17 | 1992-09-02 | Pitman Moore Inc | Vaccines |
WO1994020622A1 (en) | 1993-03-11 | 1994-09-15 | Akzo Nobel N.V. | Polypeptide fragment capable of inducing neutralising antibodies against feline immuno-deficiency virus |
US6015686A (en) * | 1993-09-15 | 2000-01-18 | Chiron Viagene, Inc. | Eukaryotic layered vector initiation systems |
US6254872B1 (en) | 1995-08-25 | 2001-07-03 | University Of Florida | Multi-subtype FIV vaccines |
ATE313629T1 (de) | 1998-08-24 | 2006-01-15 | Pfizer Prod Inc | Immunschwächevirus stamm fiv-141 der katze und dessen verwendungen |
-
2003
- 2003-08-26 US US10/648,667 patent/US7345152B2/en not_active Expired - Lifetime
- 2003-09-08 MX MXPA03008083A patent/MXPA03008083A/es active IP Right Grant
- 2003-09-08 KR KR1020030062762A patent/KR101114268B1/ko not_active IP Right Cessation
- 2003-09-09 CO CO03078836A patent/CO5500021A1/es not_active Application Discontinuation
- 2003-09-10 SI SI200332137T patent/SI1398325T1/sl unknown
- 2003-09-10 ES ES03255660T patent/ES2383075T3/es not_active Expired - Lifetime
- 2003-09-10 DK DK03255660.7T patent/DK1398325T3/da active
- 2003-09-10 EP EP10183768A patent/EP2281838A1/en not_active Withdrawn
- 2003-09-10 AT AT03255660T patent/ATE553126T1/de active
- 2003-09-10 JP JP2003318535A patent/JP4472298B2/ja not_active Expired - Fee Related
- 2003-09-10 BR BRPI0303500-0B1A patent/BR0303500B1/pt not_active IP Right Cessation
- 2003-09-10 EP EP03255660A patent/EP1398325B1/en not_active Expired - Lifetime
- 2003-09-10 PT PT03255660T patent/PT1398325E/pt unknown
- 2003-09-11 CN CN031649092A patent/CN1528791B/zh not_active Expired - Fee Related
- 2003-09-11 NZ NZ528160A patent/NZ528160A/en not_active IP Right Cessation
- 2003-09-11 ZA ZA2003/07119A patent/ZA200307119B/en unknown
- 2003-09-11 AR ARP030103289A patent/AR041230A1/es active IP Right Grant
- 2003-09-11 HR HR20030729A patent/HRP20030729A2/xx not_active Application Discontinuation
- 2003-09-11 AU AU2003246049A patent/AU2003246049A1/en not_active Abandoned
- 2003-09-12 RS YU71803A patent/RS51739B/sr unknown
- 2003-09-12 TW TW092125182A patent/TW200406421A/zh unknown
- 2003-09-12 PL PL03362164A patent/PL362164A1/xx unknown
-
2010
- 2010-09-22 AU AU2010224370A patent/AU2010224370B2/en not_active Expired
-
2012
- 2012-05-03 CY CY20121100411T patent/CY1112710T1/el unknown
Also Published As
Publication number | Publication date |
---|---|
CY1112710T1 (el) | 2016-02-10 |
KR20040024490A (ko) | 2004-03-20 |
ZA200307119B (en) | 2005-05-25 |
YU71803A (sh) | 2006-05-25 |
ATE553126T1 (de) | 2012-04-15 |
EP2281838A1 (en) | 2011-02-09 |
CN1528791B (zh) | 2012-09-05 |
HRP20030729A2 (en) | 2005-02-28 |
PL362164A1 (en) | 2004-03-22 |
BR0303500A (pt) | 2004-09-08 |
RS51739B (sr) | 2011-10-31 |
PT1398325E (pt) | 2012-05-29 |
ES2383075T3 (es) | 2012-06-18 |
KR101114268B1 (ko) | 2012-03-05 |
CN1528791A (zh) | 2004-09-15 |
BR0303500B1 (pt) | 2013-09-17 |
SI1398325T1 (sl) | 2012-06-29 |
JP2004097225A (ja) | 2004-04-02 |
NZ528160A (en) | 2005-07-29 |
AU2010224370A1 (en) | 2010-10-14 |
US7345152B2 (en) | 2008-03-18 |
AR041230A1 (es) | 2005-05-11 |
CO5500021A1 (es) | 2005-03-31 |
AU2003246049A1 (en) | 2004-04-01 |
EP1398325B1 (en) | 2012-04-11 |
US20040053224A1 (en) | 2004-03-18 |
TW200406421A (en) | 2004-05-01 |
JP4472298B2 (ja) | 2010-06-02 |
EP1398325A1 (en) | 2004-03-17 |
AU2010224370B2 (en) | 2011-07-21 |
DK1398325T3 (da) | 2012-05-21 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HUP0402192A2 (hu) | EGF receptor elleni antitesteket tartalmazó liofilizált készítmény | |
ES2307496T4 (es) | Composiciones de vacuna, antígenos y péptidos de VIH | |
NZ219113A (en) | Hiv peptide containing epitope of the env protein | |
UA85536C2 (en) | Viral antigens | |
DK1255826T3 (da) | Automatisering af proteindesign for proteinbiblioteker | |
ATE542829T1 (de) | Impfstoff | |
DE68927348D1 (de) | Künstlicher impfstoff gegen aids-virus | |
ES2129487T3 (es) | Peptidos sinteticos, anticuerpos dirigidos contra ellos y su utilizacion. | |
WO2002081655A3 (en) | Fusion protein construct and method for inducing hiv-specific serum igg and secretory iga antibodies in-vivo | |
ES2066887T3 (es) | Anticuerpo monoclonal para diferenciar individuos seropositivos hiv-2 de los hiv-1. | |
NZ535908A (en) | HIV regulatory and auxilliary peptides, antigens, vaccine compositions, immunoassay kit and a method of detecting antibodies induced by HIV | |
MXPA03008083A (es) | Anticuerpo monoclonal especifico para epitopo de glicoproteina codificada por inmunodeficiencia felina inactivada. | |
EA200200974A1 (ru) | Моноклональные антитела к рецептору лпнп человека, их получение и применение | |
DK0470980T3 (da) | Syntetiske peptider til en HIV-1-vaccine | |
DK1417222T3 (da) | Isolerede polypeptider baseret på den neutraliserende epitop af p17-proteinet fra HIV egnet til vacciner samt neutraliserende anti-p17-antistoffer, der specifikt genkender nævnte neutraliserende epitop | |
ATE370160T1 (de) | Peptide mit affinität zu gp120, und ihre verwendungen | |
WO2005047308A3 (en) | Peptide-based diagnostic reagents for sars | |
ATE544865T1 (de) | Assays für den zusammenbau von ebola-virus- nukleocapsiden | |
DK1442124T3 (da) | Polypeptidantigen, der danner en mimetisk struktur af gp41-mellemstanden | |
FR2839721B1 (fr) | Antigene polypeptidique induisant des anticorps neutralisant le vih | |
AU2002355912A1 (en) | Isolated polypeptides based on the neutralizing epitope of the p17 protein of hiv useful as vaccines, and neutralizing anti-p17 antibodies which specifically recognize said neutralizing epitope | |
DE59704477D1 (de) | Pharmazeutische antigen-/antikörperpräparation | |
TWI256306B (en) | Monoclonal antibody hybridoma capable of generating human hepatitis B virus surface antigen (HbsAg), the monoclonal antibody generated from said hybridoma, and a test kit using the same | |
TW200512215A (en) | Epitope profiles of SARS coronavirus |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FG | Grant or registration | ||
GB | Transfer or rights | ||
HC | Change of company name or juridical status |